Cargando…
CRISPR/Cas9 mediated somatic gene therapy for insertional mutations: the vibrator mouse model
Somatic gene therapy remains technically challenging, especially in the central nervous system (CNS). Efficiency of gene delivery, efficacy in recipient cells, and proportion of cells required for overall benefit are the key points needed to be considered in any therapeutic approach. Recent efforts...
Autores principales: | Fu, Xin, Zhu, Jie, Duan, Yaou, Lu, Paul, Zhang, Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982555/ https://www.ncbi.nlm.nih.gov/pubmed/35693220 http://dx.doi.org/10.1093/pcmedi/pbab021 |
Ejemplares similares
-
Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptors
por: Zhu, Jie, et al.
Publicado: (2017) -
CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers
por: Teh, Selina Shiqing K., et al.
Publicado: (2023) -
CRISPR/Cas9‐mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse
por: Guan, Yuting, et al.
Publicado: (2016) -
Two CRISPR/Cas9-mediated methods for targeting complex insertions, deletions, or replacements in mouse
por: Pineault, Kyriel M., et al.
Publicado: (2019) -
Large Genomic Fragment Deletions and Insertions in Mouse Using CRISPR/Cas9
por: Zhang, Luqing, et al.
Publicado: (2015)